Visa (NYSE:V) said that it will launch a stablecoin prefunding pilot through Visa Direct to modernize cross-border payments by allowing businesses to fund transactions with stablecoins instead of ...

Indian Institute of Technology, Delhi, will soon start its second certificate program. The program focuses on Applied Data Science and Artificial Intelligence. It is a six-month course starting ...

BOZEMAN, Mont., October 01, 2025--(BUSINESS WIRE)--Global analytics software leader FICO (NYSE: FICO) today announced a major shift in the delivery of FICO® Scores to the mortgage industry. With the ...

Mr. Khamenei's remarks come as Iranian President Masoud Pezeshkian travelled to New York for the UN General Assembly. The comments likely will constrain Pezeshkian and halt any possible outreach to ...

AstraZeneca (NASDAQ:AZN) on Friday became the latest leading drugmaker to roll out a direct-to-consumer platform in the U.S. with the launch of AstraZeneca Direct, through which the company aims to ...

Amgen launched a direct-to-patient program Oct. 6 to offer its cholesterol medication Repatha at a reduced price. The AmgenNow program will provide Repatha for $239 per month — nearly 60% below the ...

The booster stage for Firefly Aerospace’s next Alpha rocket was destroyed Monday in a fiery accident on the company’s vertical test stand in Central Texas. Engineers were testing the rocket before ...

Investment Objective - The investment objective of the Scheme is to replicate the Nifty Alpha 50 Index by investing in securities of the Nifty Alpha 50 Index in the same proportion / weightage with an ...

AdvanCell to present promising clinical trial results of ADVC001, a novel Lead-212-based PSMA-targeted alpha therapy for prostate cancer, at ESMO ...

Iran's Supreme Leader Ayatollah Ali Khamenei speaks during a meeting in Tehran, Iran, on August 24, 2025. Iran’s supreme leader on Tuesday ruled out direct talks with the United States over the ...

Bristol Myers Squibb announced an expansion of its direct-to-patient offerings, providing eligible US patients with steeply discounted prices for Eliquis (apixaban) and Sotyktu (deucravacitinib).